GW823093

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GW823093, covering 2018-03-19 to 2018-03-19. Get the full timeline:

Most recent: Clinical Trial Update: Study Of GW823093 In Japanese Subjects With Type 2 Diabetes Mellitus [Phase 2]